Located in Southwest France, the OcciLife research facility (formerly Avogadro LS) has over 25 years of experience supporting the animal and human pharma industries with preclinical studies in target and research species to GCP and GLP standards.
Established 25 years ago in South Africa to address European animal health companies’ need for efficacy studies on target species, Clinglobal expanded its service portfolio and global footprint. Today, the Clinglobal group offers a comprehensive service portfolio to Animal Health companies worldwide.
This collaboration is a significant step forward, promising to enhance Clinglobal’s services, solutions, and support within Europe. Moving closer to its regional strategic partners enables Clinglobal to deliver even more effective and efficient services to the industry.
The OcciLife site will start transitioning onto the Clinglobal Group’s compliance, quality management, data management and IT platforms this year, and critical operational alignment will be completed in 2025.
The Clinglobal Group and OcciLife teams are committed to continuing to partner with European and international organisations to better lives by accelerating animal health innovation.
About the Clinglobal Group
Privately owned, the Clinglobal group’s five contract research organisations (CROs) specialise in distinctive yet complementary areas of expertise: Clinvet offers in vitro and in vivo preclinical and clinical safety and efficacy studies on target species; Clindata proposes integral data management and statistical analysis support; Clinomics specialises in molecular biology and recombinant protein expression R&D services; Rtilab is an R&D microbiology and diagnostics laboratory; and Clinglobal offers central contract management and product development support services, including but not limited to regulatory affairs, quality assurance, consulting and field clinical trials.
About OcciLife
Founded in 1998 as Avogadro, OcciLife is a privately owned CRO that provides in vivo studies on target and research animals for the animal and human health industries. The team is well-versed in pharmacokinetics and safety studies, and the site is AAALAC and GLP-accredited and capable of performing GCP studies.
